Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soon Thye Lim

Showing results (41-50 of 184) with videos related to

Pageof 19
Sort By:
Leukemia & Lymphoma|May 2, 2013
Cytomegalovirus infection and end-organ disease in Asian patients with lymphoma receiving chemotherapyMatthew Rong Jie Tay, Soon Thye Lim, Miriam Tao, et al.
Acta Oncologica (Stockholm, Sweden)|October 21, 2009
Second hematologic malignancies after ABVD: Two case reports and a retrospective study of 183 Hodgkin lymphoma patientsCarrie Leong, Joanne Ngeow, Iain Tan, et al.
Leukemia & Lymphoma|August 6, 2019
Cell-of-origin and bone marrow involvement increase specificity of defining patients with diffuse large B-cell lymphoma at high risk of CNS relapse: a study of 793 patients treated with chemoimmunotherapy in AsiaShin Yeu Ong, Colin Phipps, Chandramouli Nagarajan, et al.
International Journal of Cancer|June 11, 2015
Gender and ethnic differences in incidence and survival of lymphoid neoplasm subtypes in an Asian population: Secular trends of a population-based cancer registry from 1998 to 2012Raymond Boon Tar Lim, En Yun Loy, Gek Hsiang Lim, et al.
Cancer|November 10, 2009
Hepatitis B virus reactivation and role of antiviral prophylaxis in lymphoma patients with past hepatitis B virus infection who are receiving chemoimmunotherapyYu Xuan Koo, Daniel S W Tan, Iain B Tan, et al.
Asia-Pacific Journal of Clinical Oncology|February 22, 2011
Comparison of daily filgrastim and pegfilgrastim to prevent febrile neutropenia in Asian lymphoma patientsAlexandre Chan, Xue Zhen Leng, Joen Y L Chiang, et al.
The Lancet. Oncology|November 2, 2013
Management of B-cell non-Hodgkin lymphoma in Asia: resource-stratified guidelinesDaryl Tan, Soo Yong Tan, Soon Thye Lim, et al.
Plos One|February 13, 2016
Routine Primary Prophylaxis for Febrile Neutropenia with Biosimilar Granulocyte Colony-Stimulating Factor (Nivestim) or Pegfilgrastim Is Cost Effective in Non-Hodgkin Lymphoma Patients undergoing Curative-Intent R-CHOP ChemotherapyXiao Jun Wang, Tiffany Tang, Mohamad Farid, et al.
Acta Oncologica (Stockholm, Sweden)|January 14, 2011
A promising new regimen for the treatment of advanced extranodal NK/T cell lymphomaMohamad Farid, Ying Wei Yau, Kevin Tay, et al.
Annals of Nuclear Medicine|March 8, 2021
The exact Deauville score, NABS score and high SUVmax predicts outcome in extranodal natural killer/T-cell lymphomaHian Liang Huang, Pei Ing Ngam, Khee Ming Tan, et al.
Pageof 19

Showing results (41-50 of 184) with videos related to

Sort By:
Pageof 19
Leukemia & Lymphoma|May 2, 2013
Cytomegalovirus infection and end-organ disease in Asian patients with lymphoma receiving chemotherapyMatthew Rong Jie Tay, Soon Thye Lim, Miriam Tao, et al.
Acta Oncologica (Stockholm, Sweden)|October 21, 2009
Second hematologic malignancies after ABVD: Two case reports and a retrospective study of 183 Hodgkin lymphoma patientsCarrie Leong, Joanne Ngeow, Iain Tan, et al.
Leukemia & Lymphoma|August 6, 2019
Cell-of-origin and bone marrow involvement increase specificity of defining patients with diffuse large B-cell lymphoma at high risk of CNS relapse: a study of 793 patients treated with chemoimmunotherapy in AsiaShin Yeu Ong, Colin Phipps, Chandramouli Nagarajan, et al.
International Journal of Cancer|June 11, 2015
Gender and ethnic differences in incidence and survival of lymphoid neoplasm subtypes in an Asian population: Secular trends of a population-based cancer registry from 1998 to 2012Raymond Boon Tar Lim, En Yun Loy, Gek Hsiang Lim, et al.
Cancer|November 10, 2009
Hepatitis B virus reactivation and role of antiviral prophylaxis in lymphoma patients with past hepatitis B virus infection who are receiving chemoimmunotherapyYu Xuan Koo, Daniel S W Tan, Iain B Tan, et al.
Asia-Pacific Journal of Clinical Oncology|February 22, 2011
Comparison of daily filgrastim and pegfilgrastim to prevent febrile neutropenia in Asian lymphoma patientsAlexandre Chan, Xue Zhen Leng, Joen Y L Chiang, et al.
The Lancet. Oncology|November 2, 2013
Management of B-cell non-Hodgkin lymphoma in Asia: resource-stratified guidelinesDaryl Tan, Soo Yong Tan, Soon Thye Lim, et al.
Plos One|February 13, 2016
Routine Primary Prophylaxis for Febrile Neutropenia with Biosimilar Granulocyte Colony-Stimulating Factor (Nivestim) or Pegfilgrastim Is Cost Effective in Non-Hodgkin Lymphoma Patients undergoing Curative-Intent R-CHOP ChemotherapyXiao Jun Wang, Tiffany Tang, Mohamad Farid, et al.
Acta Oncologica (Stockholm, Sweden)|January 14, 2011
A promising new regimen for the treatment of advanced extranodal NK/T cell lymphomaMohamad Farid, Ying Wei Yau, Kevin Tay, et al.
Annals of Nuclear Medicine|March 8, 2021
The exact Deauville score, NABS score and high SUVmax predicts outcome in extranodal natural killer/T-cell lymphomaHian Liang Huang, Pei Ing Ngam, Khee Ming Tan, et al.
Pageof 19